Compare · head to head
Ilyang Pharmaceutical vs PharmGen Science
PharmGen Science ranks higher overall — 360 rank 74 vs 30.
PharmGen Science leads on Value (57 vs 48) and Safety (73 vs 31). Ilyang Pharmaceutical leads on Quality (68 vs 54). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7007570005 | KR7004720009 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 30 | 74 |
| Value | 48 | 57 |
| Quality | 68 | 54 |
| Growth | 40 | NR |
| Safety | 31 | 73 |
| Sentiment | 43 | 41 |
| Quality details | ||
| Profitability | 64 | 70 |
| Cash Truth | 72 | 38 |
Ilyang Pharmaceutical vs Daewoong PharmaceuticalIlyang Pharmaceutical vs Aprogen BiologicsIlyang Pharmaceutical vs Reyon PharmaceuticalIlyang Pharmaceutical vs Chongkundang HoldingsAdd a third stock →
Full analyses: Ilyang Pharmaceutical · PharmGen Science
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100